For: | Bellon A, Nguyen K. Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach. World J Psychiatr 2021; 11(7): 316-324 [PMID: 34327124 DOI: 10.5498/wjp.v11.i7.316] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v11/i7/316.htm |
Number | Citing Articles |
1 |
Catherine W. Bennett, Lauren Gensler, David R. Goldsmith. Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic. Community Mental Health Journal 2023; 59(4): 641 doi: 10.1007/s10597-022-01045-2
|
2 |
Daria A. Kamaeva, Daria V. Kazantseva, Anastasiia S. Boiko, Irina A. Mednova, Liudmila P. Smirnova, Elena G. Kornetova, Svetlana A. Ivanova. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia. Biomedicines 2023; 11(4): 1179 doi: 10.3390/biomedicines11041179
|
3 |
Faiez Iqbal, Aneemaa Narayan, Mallicka Chatrath, Mohammad Iqbal. Examining the Association Between Serotonergic Antidepressants and Blood Transfusion Requirements in Orthopaedic Surgery: A Comprehensive Analysis. Cureus 2023; doi: 10.7759/cureus.45988
|
4 |
O. Godin, B. Pignon, A. Szoke, L. Boyer, B. Aouizerate, B. Schorr, M. André, D. Capdevielle, I. Chereau, N. Coulon, R. Dassing, C. Dubertret, B. Etain, S. Leignier, P.M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, M. Urbach, F. Schürhoff, M. Leboyer, G. Fond. 3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110641 doi: 10.1016/j.pnpbp.2022.110641
|
5 |
Joseph Dao, Savreen Saran, Melody Wang, Christina Michael, Nhu-y Phan, Alfredo Bellon. A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia. Brain Sciences 2023; 13(2): 368 doi: 10.3390/brainsci13020368
|
6 |
Hélène Verdoux, Clélia Quiles, Jose de Leon. Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations. Schizophrenia Research 2024; 268: 243 doi: 10.1016/j.schres.2023.10.003
|